scispace - formally typeset
T

Trupti N. Brahmbhatt

Researcher at Naval Medical Research Center

Publications -  5
Citations -  282

Trupti N. Brahmbhatt is an academic researcher from Naval Medical Research Center. The author has contributed to research in topics: Bacillus anthracis & Exosporium. The author has an hindex of 5, co-authored 5 publications receiving 265 citations. Previous affiliations of Trupti N. Brahmbhatt include Uniformed Services University of the Health Sciences.

Papers
More filters
Journal ArticleDOI

Bacillus anthracis exosporium protein BclA affects spore germination, interaction with extracellular matrix proteins, and hydrophobicity.

TL;DR: It is suggested that BclA acts as a shield to not only reduce the ease with which spores germinate but also change the surface properties of the spore, which, in turn, may impede the interaction with host matrix substances.
Journal ArticleDOI

Recombinant Exosporium Protein BclA of Bacillus anthracis Is Effective as a Booster for Mice Primed with Suboptimal Amounts of Protective Antigen

TL;DR: The concept of rBclA as being a safe and effective boost for a PA-primed individual against anthrax is supported and it is suggested that such rBClA-enhanced protection occurs by the induction of spore-opsonizing and germination-inhibiting antibodies.
Journal ArticleDOI

Arbovirus detection in insect vectors by rapid, high-throughput pyrosequencing.

TL;DR: Dengue virus type 1 RNA was sufficiently concentrated in the mosquito that its detection was feasible using current high-throughput sequencing instrumentation, and some of the components of the mosquito microflora were identified on the basis of the sequence of expressed RNA.
Journal ArticleDOI

Rapid Identification of Genetic Modifications in Bacillus anthracis Using Whole Genome Draft Sequences Generated by 454 Pyrosequencing

TL;DR: The Roche 454-based pyrosequencing can generate whole genome draft sequences of deep and broad enough coverage of a bacterial genome in less than 24 hours, and unbiased identification of known as well as heretofore-unreported genetic modifications that include indels and single nucleotide polymorphisms conferring antibiotic and phage resistances is feasible within the next 12 hours.